Group 1 - The flu season in Shanghai has started earlier this year, entering the peak period from late November to early January, with the dominant strain being H3N2 [1] - The so-called "K strain" circulating online is a variant of the H3N2 strain, not a new virus, as confirmed by health officials [1] - The current flu virus activity is at a high level, with multiple respiratory diseases posing risks due to fluctuating temperatures [1] Group 2 - Community health service centers in Shanghai are operating seven days a week to optimize testing and early identification of flu cases [2] - Medical institutions are enhancing their capacity for flu treatment, ensuring that fever clinics in secondary hospitals are fully operational and equipped [2] - The city is improving the medical process, including pre-examination and triage, and utilizing "Internet + healthcare" for online consultations [2] Group 3 - It is recommended to get the flu vaccine before the season starts, ideally in October, as it takes 2 to 4 weeks to develop antibodies [3] - The flu vaccine can provide 70%-80% protection against severe illness, even if administered during the peak season [3] - Antiviral medications are categorized into two types: neuraminidase inhibitors and RNA polymerase inhibitors, with the best effect when taken within 48 hours of infection [3]

当前正是流感流行季。中国中医科学院广安门医院急诊科主任医师齐文升说，中医预防强调内养正 气、外慎邪气，流感的发生取决于人体内部"正气"（免疫力）的盛衰和"疫戾之气"（病毒）的强弱，可 以通过综合调养的方法巩固自身的"防御能力"。 齐文升建议，内养正气，可适当食用温补清润食材，尽量保证充足睡眠，还可采用艾灸和中药泡脚 等方法温通经络、调整阴阳；外慎邪气，可定期在室内用艾叶、苍术煮水熏蒸，也可佩戴艾叶、苍术、 藿香等中药材做成的香囊以辟秽解毒，或以苍术、陈皮、白茅根等中药材冲泡代茶饮。 新华社北京12月16日电 题：抗流感、重养生，巧用中医方法安度寒冬 新华社记者 田晓航 冬至将至，天气渐寒，眼下正是流感、心血管病的高发季。如何用好中医药方法养生防病，呵护 好"一老一小"？12月16日，国家中医药局举行发布会，邀请中医专家为公众答疑解惑。 防流感：内养正气，外慎邪气 同时，冬季运动推荐太极拳、八段锦等和缓运动，以身体微微发热为度；还需通过戴围巾、泡脚等 方式，做好颈、足等重点部位的保暖。 冬季寒冷易诱发心脑血管疾病，在中医看来，预防应顺应自然，扶正祛邪。专家介绍，应注重保 暖，避免寒邪引起的凝滞收缩对心血管造成不 ...

截至12月6日的一周，美国公共卫生实验室共报告547份流感病毒样本，其中525份为甲型流感病毒，22 份为乙型流感病毒。当周美国报告本流感季首例与流感相关的儿童死亡病例。 美疾控中心表示，本流感季美国已分发超过1.27亿剂流感疫苗，并建议6个月及以上人群每年接种流感 疫苗，以降低感染和重症风险。 据美疾控中心网站介绍，美国流感季通常在秋冬两季，每年12月至次年2月为高峰期。每年接种流感疫 苗不仅有助于预防流感感染，还可降低重症、住院和死亡风险，并减少社区传播。此外，感染流感后应 尽早开始使用抗病毒药物，这对老年人、慢性病患者等发生严重并发症风险较高的人群尤为重要。 美国疾病控制和预防中心公布的最新估计数据显示，美国本流感季以来已有约290万例流感病例，其中 住院病例约3万例，死亡病例约1200例。 （文章来源：新华社） 据美疾控中心介绍，美国本流感季刚刚开始，甲型H3N2亚型流感病毒是该流感季最主要的流行毒株。 全美大部分地区的流感活动水平仍在持续上升。 ...

当前，正值呼吸道传染病高发季节，中国疾控中心12月11日公布的监测数据显示，12月1日—7日，门急 诊流感病毒检出阳性率为54.2%。流感处于高流行水平，流感病毒检测阳性率呈上升趋势，但上升幅度 趋缓。 如何区分流感和普通感冒？如何预防和治疗流感？ 如何区分流感和普通感冒 "现阶段我国检出的病原体都是常见的已知病原体，没有发现由未知病原体或者由这个病原体导致的新 发传染病。"中国疾控中心研究员彭质斌介绍。 在哪里可以接种流感疫苗？社区卫生服务中心、大型医院、疾控中心都可以。以北京为例，目前已经有 471家流感疫苗接种门诊提供流感疫苗接种服务。接种流感疫苗通常需提前预约，部分机构支持线上平 台或电话预约，接种时需携带身份证，儿童需带预防接种证。多地采取措施方便居民接种，在浙江，部 分乡镇（街道）、村（社区），采取包车接送的方式将老人从村里送到接种门诊，或设立"流动接种 车"深入偏远乡村，组织医护人员上门服务等。 按照中国疾控中心发布的《中国流感疫苗预防接种技术指南（2025—2026）》，6月龄至8岁儿童首次接 种灭活疫苗需要接种2剂次，间隔大于等于4周；既往接种过，本年度接种1剂次即可。如果选择减毒活 疫苗（ ...

Core Viewpoint - The article provides recommendations for traditional Chinese medicine (TCM) methods to help alleviate flu symptoms and reduce infection risks during the flu season. Treatment and Prevention - A preventive formula is suggested for high-risk groups, focusing on enhancing immunity and preemptively combating the flu virus. The formula includes 10 grams each of raw astragalus, daqingye, and eleutherococcus, to be taken as a decoction twice daily [3]. - The components of the formula are explained: raw astragalus boosts immunity, daqingye has heat-clearing and detoxifying properties, and eleutherococcus strengthens energy and supports the body's defenses [3]. External Treatment Methods - External treatment methods are recommended for symptom relief, especially for those who find it difficult to take medicine or have mild symptoms. Techniques include guasha along the "governing vessel" on the back and cupping therapy [4]. - Specific scenarios for these methods include high fever (above 38.5°C) and severe throat pain, with instructions on how to perform these techniques safely [4][5]. Pediatric Care - Gentle external treatment methods are highlighted for children, emphasizing safety and effectiveness. Techniques include pediatric massage to reduce fever, clear phlegm, and relieve nasal congestion [6]. - Specific massage techniques are outlined, such as pushing from the center of the forehead to the hairline and massaging around the ears and temples [6][7]. Expert Contributions - The article features insights from experts in traditional Chinese medicine, including directors from affiliated hospitals, emphasizing the safety and efficacy of these methods for flu management [8].

★ 去医院时，前往医疗机构就诊、陪诊、陪护、探视时； ★ 前往"密闭人多"场所时，前往环境闷、人多密集的超市、候车大厅，或乘坐公共交通工具时； 当前，多地正处于流感流行高峰期，做好个人防护，预防流感尤为重要。科学佩戴口罩可以有效预防呼吸道传染病。 哪些场景建议佩戴口罩？ ★ 自己"中招"了。出现发热、咽痛、咳嗽等流感样症状期间； ★ 去"脆弱人群集中场所"时，养老机构、社会福利机构、幼儿园等脆弱人群集中场所，外来人员进入时和公共服务人员工作期间建议佩戴口罩。 ★ "脆弱人群"出门时，老人、儿童、慢性病患者、孕妇等重点人群前往人多室内公共场所时； ★ 身边有人"不舒服"时，如果同事、同学或家人出现咳嗽、发热等呼吸道症状，和他们一起学习、生活、工作时。 （来源：北京市疾病预防控制中心） ...

2025.12. 04 本文字数：1786，阅读时长大约3分钟 作者 | 第一财经 林志吟 根据中国疾控发布的2025年第48周中国流感监测周报，南、北方省份流感活动上升，全国共报告 1541起流感样病例暴发疫情。 第一财经记者根据中国流感监测周报统计的数据显示，从2025年11月3日以来，截至11月30日，全 国共报告流感样病例暴发疫情已达到4351起，其中3313起跟A(H3N2）流感有关，占比约76.14%。 而像奥司他韦这样的抗流感病毒药物是否已产生了耐药性？该问题近日也引发市场关注。 奥司他韦是否耐药了 根据中国流感监测周报，2025年第48周（2025年11月24日－2025年11月30日），南方省份哨点医 院报告的ILI（流感样病例）%为10.3%，高于前一周水平（7.8%），高于2022年、2023年和2024 年同期水平（3.2%、8.7%和3.5%）。 2025年第48周，北方省份哨点医院报告的ILI%为9.1%，高于前一周水平 （8.6%）， 高于2022 年、2023年和2024年同期水平（2.0%、7.3%和4.4%）。 近日中国疾控中心方面也预计，全国在12月上中旬流感达峰的可能性 ...

北京青年报记者昨日从市疾控中心了解到，当前本市呼吸道传染病以流感为主，未出现流感与其他 呼吸道传染病的叠加流行，全市发热门诊就诊人数也低于前两年高峰水平。今年10月底以来，本市流感 活动强度持续上升，于11月中旬进入流行期，较2024—2025流行季提前约四周。当前流感样病例病毒阳 性率虽高于2024-25流行季峰值，但仍低于2023年3月高峰，目前流感上升势头已经减缓，本市流感活动 强度或已达峰。后续需要关注老年人、慢性基础病患者等人群感染后加重基础疾病的风险。 市疾控中心传染病地方病控制所所长张代涛介绍，本次流感流行株为甲型H3N2亚型，占比为 99.8%。疫苗保护效果预计与往年H3N2流行时相似，对神经氨酸酶抑制剂和聚合酶抑制剂等常用流感 治疗药物敏感。张代涛提醒，接种流感疫苗是预防流感及其严重并发症的最有效手段。 养老机构要严格落实健康监测和发热报告制度，做到"早发现、早检测、早治疗"；发现老人出现发 热、咳嗽等流感样症状时，及时就医诊治，畅通重症患者绿色转诊通道，提升重症救治效率；加强工作 人员健康管理和个人防护，规范佩戴口罩，发热及时离岗；做好环境卫生，对房间、食堂等人员聚集的 场所要经常开窗，保 ...

Financial Data and Key Metrics Changes - The company anticipates a greater than $5 billion commercial opportunity starting at the end of the decade and escalating into the early 2030s [10] - The influenza program is expected to provide protection to approximately 110 million people in the U.S., with 85 million being high-risk or immunocompromised individuals [9] Business Line Data and Key Metrics Changes - The launch of Ohtuvayre for COPD treatment has received excellent feedback, and the company sees a significant opportunity to scale this product [17][18] - Winrevair in pulmonary arterial hypertension (PAH) is meeting high expectations, with continuous positive feedback from the medical community [28][29] Market Data and Key Metrics Changes - In the last influenza season, there were 1.6 million hospitalizations due to influenza in the U.S., highlighting the high unmet medical need [10] - The company is seeing strong uptake in the triple segment of the PAH population, with plans to penetrate further into the dual category [32] Company Strategy and Development Direction - The company is focusing on the commercialization of CD388, an antiviral treatment for influenza that is strain agnostic and effective across various populations [6][8] - The strategy includes leveraging existing commercial capabilities to enhance the launch and market penetration of new products like Ohtuvayre and Winrevair [20][21] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the significant unmet need in the influenza market and the potential for CD388 to address this issue effectively [5][6] - The company is optimistic about the future of its respiratory portfolio and the potential for new products to transform patient outcomes [19][20] Other Important Information - The company is preparing for the launch of an oral PCSK9 inhibitor, which is expected to improve access and adherence for patients needing cholesterol management [40][46] - The company is also exploring multiple indications for its TL1A mechanism, which has shown promise in inflammatory and fibrotic diseases [67][68] Q&A Session Summary Question: Insights on the Cidara deal and its growth opportunity - Management highlighted the high unmet medical need for influenza treatment and the strain-agnostic efficacy of CD388, which is expected to be a significant commercial opportunity [5][6] Question: Commercial approach for high-risk patients - The company plans to include both vaccinated and unvaccinated high-risk individuals in the phase 3 program, with payer research indicating a favorable price point for the treatment [12][13] Question: Feedback on Ohtuvayre and its market potential - The feedback from customers has been excellent, and the company believes it can significantly scale the product using its commercial engine [17][18] Question: Future steps for Winrevair in PAH - Management expressed confidence in the product's performance and noted that they are seeing positive feedback and uptake in the market [28][29] Question: Expectations for the oral PCSK9 program - The company anticipates that the oral PCSK9 will provide robust LDL lowering and improve access for patients, potentially changing treatment guidelines [40][46] Question: Update on Gardasil and vaccine portfolio - The company expects modest growth for Gardasil moving forward, with ongoing efforts to drive vaccination rates globally [54][55] Question: TL1A mechanism and future indications - Management is optimistic about the TL1A mechanism's potential across multiple indications, with several phase 2 studies planned [67][68]

齐鲁晚报·齐鲁壹点 姜曼 不管流感流行毒株如何变化，专家介绍，它们的防护措施是一致的，做好个人防护是预防流感的关键， 主要是养成良好的个人卫生习惯；加强学校、家庭内的疾病预防；及时接种流感疫苗。 据悉，目前，全市共设立252家预防接种门诊开展流感疫苗接种服务，市民可以关注"临沂疾控"微信公 众号，在《疾控服务》栏目中点击"流感疫苗接种点"查找，根据需要就近接种。由于每年流感流行的毒 株会有变化，相对应的流感疫苗也是不断调整的，因此建议大家每年都要接种疫苗，进而降低感染的风 险。需要提醒的是，如果已经出现了发烧、咳嗽等流感样症状，或者确诊了流感，需要等症状消失，身 体基本恢复后再接种。 普通感冒主要是由鼻病毒、呼吸道合胞病毒等常见病原体感染引起，传染性和一般症状较轻，多表现为 鼻塞、咳嗽等症状，高烧症状少见，并且病程较短。流行性感冒是由流感病毒感染引起的，相比普通感 冒，传染性更强、发病更急、症状更重，常会出现高热、咳嗽、身体酸痛、乏力等全身症状，部分患者 可能出现肺炎、脑炎等并发症，重症者可能危及生命。 根据监测，临沂市本轮流感流行的主要毒株是甲型H3N2亚型。甲型H3N2是常见的季节性流感病毒之 一，在全球 ...